Table 2.
Compounds | Cell line | Downregulated pro-inflammatory mediators | Upregulated anti-inflammatory mediators | Ref. |
---|---|---|---|---|
genistein, equol | RAW 264.7 | NO, PGE2 | [136] | |
genistein, | RAW 264.7 | TNFα, IL-6, iNOS, NFκB | IL-10 | [114] |
daidzein, | TNFα, IL-6, iNOS, NFκB | |||
formononetin | iNOS | |||
biochanin A | TNFα, IL-6, iNOS, NFκB, Cox-2 | IL-10 | ||
equol | TNFα, IL-6, COX-2 | |||
ODMA | TNFα, IL-6 | |||
genistein | HBMEC | TNFα, IL-1β, monocyte chemoattractant protein-1, IL-8, intercellular adhesion molecule-1 | [137] | |
genistein, daidzein | murine J774 macrophages | iNOS, NO | [138] | |
genistein | Human chondrocytes | COX-2, NO | [139] | |
biochanin A | MC3T3-E1 cells | TNFα, IL-6, NO | [140] | |
genistein | PBLs | TNFα, IL-8 | [141] | |
genistein | mesencephalic neuron-glia cultures | TNFα, NO, superoxide | [142] | |
daidzein, formononetin | mesencephalic neuron-glia cultures | TNFα, NO, superoxide | [143] | |
biochanin A | mesencephalic neuron-glia cultures | TNFα, NO, superoxide | [144] | |
genistein | alveolar macrophages | TNFα | [145] | |
daidzein | PBMC | higher concentrations reduced IL-10 and IFN-γ levels | low concentration increased IL-2, IL-4,and IFN-γ | [146] |
genistein | IL-2, IL-4, IL-10, IFN-γ mRNA and protein | |||
genistein | RAW 264.7 | NO, PGE2 | [147] | |
genistein | RAW 264.7 | PGE2, iNOS, COX-2 | [148] | |
genistein, daidzein, glycetein | RAW 264.7 | NO, iNOS | [149] | |
genistein, daidzein, equol | MCF-7 cells | COX-2 | [150] |
HBMEC (human brain microvascular endothelial cells); MC3T3-E1 (osteoblasts); MCF-7 (human breast cancer cell line); PBL (human peripheral blood mononuclear and/or polymorphonuclear leukocytes); PBMC (peripheral blood mononuclear cells); RAW 264.7 (mouse macrophage).